share_log

Agios Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director FOUSE JACQUALYN A

SEC ·  Jun 25, 2024 04:17
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more